Exploring safer alternatives such as laser skin whitening can provide similar, if not better, results with fewer associated risks
Not all adolescents respond equally to GLP-1 therapies, suggesting that genetic and metabolic profiling could help determine which patients benefit most from single, dual (GLP-1/GIP or GLP-1/GCGR), or triple agonists
Chem Biol 20:161167 Swee LK, Guimaraes CP, Sehrawat S, Spooner E, Barrasa MI, Ploegh HL (2013) Sortase-mediated modification of DEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes
In the world of weight management and diabetes control, GLP-1 (glucagon-like peptide-1) drugs have emerged as a highly effective treatment
Experiments measuring glucose-stimulated GIP secretion after inhibiting chylomicron release (Pluronic 818) or basolateral hydrolysis of chylomicrons (poloxamer-407) may help delineate the exact contribution of each nutrient